1	Modulation	_	NN	_	_	0	ROOT	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	apoptosis	_	NN	_	_	2	PMOD	_	_
4	in	_	IN	_	_	1	NMOD	_	_
5	human	_	JJ	_	_	8	NMOD	_	_
6	myeloid	_	JJ	_	_	8	NMOD	_	_
7	leukemic	_	JJ	_	_	8	NMOD	_	_
8	cells	_	NNS	_	_	4	PMOD	_	_
9	by	_	IN	_	_	1	NMOD	_	_
10	GM-CSF	_	NN	_	_	9	PMOD	_	_
11	.	_	.	_	_	1	P	_	_
		
1	Apoptosis	_	NN	_	_	7	VMOD	_	_
2	(	_	(	_	_	5	P	_	_
3	programmed	_	VBN	_	_	5	NMOD	_	_
4	cell	_	NN	_	_	5	NMOD	_	_
5	death	_	NN	_	_	1	PRN	_	_
6	)	_	)	_	_	5	P	_	_
7	regulates	_	VBZ	_	_	0	ROOT	_	_
8	cell	_	NN	_	_	10	NMOD	_	_
9	population	_	NN	_	_	10	NMOD	_	_
10	size	_	NN	_	_	7	VMOD	_	_
11	.	_	.	_	_	7	P	_	_
		
1	To	_	TO	_	_	21	VMOD	_	_
2	determine	_	VB	_	_	1	IM	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	mechanisms	_	NNS	_	_	2	VMOD	_	_
5	whereby	_	WRB	_	_	12	VMOD	_	_
6	hematopoietic	_	JJ	_	_	8	NMOD	_	_
7	growth	_	NN	_	_	8	NMOD	_	_
8	factors	_	NNS	_	_	12	VMOD	_	_
9	(	_	(	_	_	10	P	_	_
10	HGFs	_	NNS	_	_	8	PRN	_	_
11	)	_	)	_	_	10	P	_	_
12	modulate	_	VBP	_	_	4	NMOD	_	_
13	apoptosis	_	NN	_	_	12	VMOD	_	_
14	in	_	IN	_	_	12	VMOD	_	_
15	human	_	JJ	_	_	18	NMOD	_	_
16	myeloid	_	JJ	_	_	18	NMOD	_	_
17	leukemic	_	JJ	_	_	18	NMOD	_	_
18	cells	_	NNS	_	_	14	PMOD	_	_
19	,	_	,	_	_	21	P	_	_
20	we	_	PRP	_	_	21	VMOD	_	_
21	evaluated	_	VBD	_	_	0	ROOT	_	_
22	the	_	DT	_	_	23	NMOD	_	_
23	roles	_	NNS	_	_	21	VMOD	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	protein	_	NN	_	_	24	PMOD	_	_
26	and	_	CC	_	_	25	COORD	_	_
27	mRNA	_	NN	_	_	26	CONJ	_	_
28	synthesis	_	NN	_	_	27	COORD	_	_
29	for	_	IN	_	_	23	NMOD	_	_
30	altering	_	VBG	_	_	29	PMOD	_	_
31	apoptosis	_	NN	_	_	30	VMOD	_	_
32	in	_	IN	_	_	31	NMOD	_	_
33	growth	_	NN	_	_	39	NMOD	_	_
34	factor-stimulated	_	JJ	_	_	33	AMOD	_	_
35	vs.	_	CC	_	_	33	COORD	_	_
36	quiescent	_	JJ	_	_	35	CONJ	_	_
37	leukemic	_	JJ	_	_	39	NMOD	_	_
38	TF1	_	NN	_	_	39	NMOD	_	_
39	cells	_	NNS	_	_	32	PMOD	_	_
40	.	_	.	_	_	21	P	_	_
		
1	Lysates	_	NNS	_	_	18	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	cells	_	NNS	_	_	2	PMOD	_	_
4	from	_	IN	_	_	3	NMOD	_	_
5	the	_	DT	_	_	8	NMOD	_	_
6	granulocyte-macrophage	_	JJ	_	_	8	NMOD	_	_
7	colony-stimulating	_	JJ	_	_	8	NMOD	_	_
8	factor	_	NN	_	_	10	AMOD	_	_
9	(	_	(	_	_	10	P	_	_
10	GM-CSF	_	NN	_	_	16	NMOD	_	_
11	)	_	)	_	_	10	P	_	_
12	-dependent	_	JJ	_	_	10	AMOD	_	_
13	myeloid	_	JJ	_	_	16	NMOD	_	_
14	leukemic	_	JJ	_	_	16	NMOD	_	_
15	cell	_	NN	_	_	16	NMOD	_	_
16	line	_	NN	_	_	17	NMOD	_	_
17	TF1	_	NN	_	_	4	PMOD	_	_
18	were	_	VBD	_	_	0	ROOT	_	_
19	separated	_	VBN	_	_	18	VC	_	_
20	into	_	IN	_	_	19	VMOD	_	_
21	high	_	JJ	_	_	23	NMOD	_	_
22	molecular	_	JJ	_	_	23	NMOD	_	_
23	weight	_	NN	_	_	27	NMOD	_	_
24	(	_	(	_	_	25	P	_	_
25	HMW	_	NN	_	_	23	PRN	_	_
26	)	_	)	_	_	25	P	_	_
27	pellets	_	NNS	_	_	20	PMOD	_	_
28	of	_	IN	_	_	27	NMOD	_	_
29	intact	_	JJ	_	_	30	NMOD	_	_
30	DNA	_	NN	_	_	28	PMOD	_	_
31	and	_	CC	_	_	27	COORD	_	_
32	supernatants	_	NNS	_	_	31	CONJ	_	_
33	of	_	IN	_	_	32	NMOD	_	_
34	fragmented	_	JJ	_	_	40	NMOD	_	_
35	low	_	JJ	_	_	40	NMOD	_	_
36	MW	_	NN	_	_	40	NMOD	_	_
37	(	_	(	_	_	40	P	_	_
38	LMW	_	NN	_	_	40	NMOD	_	_
39	)	_	)	_	_	40	P	_	_
40	DNA	_	NN	_	_	33	PMOD	_	_
41	,	_	,	_	_	18	P	_	_
42	and	_	CC	_	_	18	COORD	_	_
43	the	_	DT	_	_	44	NMOD	_	_
44	DNA	_	NN	_	_	49	VMOD	_	_
45	purified	_	VBN	_	_	44	APPO	_	_
46	from	_	IN	_	_	45	VMOD	_	_
47	these	_	DT	_	_	48	NMOD	_	_
48	fractions	_	NNS	_	_	46	PMOD	_	_
49	was	_	VBD	_	_	42	CONJ	_	_
50	quantified	_	VBN	_	_	49	VC	_	_
51	.	_	.	_	_	18	P	_	_
		
1	In	_	IN	_	_	20	VMOD	_	_
2	the	_	DT	_	_	3	NMOD	_	_
3	absence	_	NN	_	_	1	PMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	both	_	CC	_	_	6	DEP	_	_
6	GM-CSF	_	NN	_	_	4	PMOD	_	_
7	and	_	CC	_	_	6	COORD	_	_
8	fetal	_	JJ	_	_	10	NMOD	_	_
9	bovine	_	JJ	_	_	10	NMOD	_	_
10	serum	_	NN	_	_	7	CONJ	_	_
11	(	_	(	_	_	12	P	_	_
12	FBS	_	NN	_	_	10	PRN	_	_
13	)	_	)	_	_	12	P	_	_
14	,	_	,	_	_	20	P	_	_
15	70	_	CD	_	_	16	NMOD	_	_
16	%	_	NN	_	_	20	VMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	DNA	_	NN	_	_	17	PMOD	_	_
20	was	_	VBD	_	_	0	ROOT	_	_
21	fragmented	_	JJ	_	_	20	VMOD	_	_
22	after	_	IN	_	_	20	VMOD	_	_
23	3	_	CD	_	_	24	NMOD	_	_
24	days	_	NNS	_	_	22	PMOD	_	_
25	in	_	IN	_	_	24	NMOD	_	_
26	culture	_	NN	_	_	25	PMOD	_	_
27	,	_	,	_	_	20	P	_	_
28	with	_	IN	_	_	20	VMOD	_	_
29	a	_	DT	_	_	33	NMOD	_	_
30	characteristic	_	JJ	_	_	33	NMOD	_	_
31	apoptotic	_	JJ	_	_	33	NMOD	_	_
32	ladder-like	_	JJ	_	_	33	NMOD	_	_
33	pattern	_	NN	_	_	28	PMOD	_	_
34	on	_	IN	_	_	33	NMOD	_	_
35	agarose	_	NN	_	_	37	NMOD	_	_
36	gel	_	NN	_	_	37	NMOD	_	_
37	electrophoresis	_	NN	_	_	34	PMOD	_	_
38	,	_	,	_	_	20	P	_	_
39	whereas	_	IN	_	_	20	VMOD	_	_
40	this	_	DT	_	_	41	NMOD	_	_
41	proportion	_	NN	_	_	42	VMOD	_	_
42	had	_	VBD	_	_	39	SUB	_	_
43	initially	_	RB	_	_	42	VMOD	_	_
44	been	_	VBN	_	_	42	VC	_	_
45	<	_	RB	_	_	47	NMOD	_	_
46	5	_	CD	_	_	45	DEP	_	_
47	%	_	NN	_	_	44	VMOD	_	_
48	.	_	.	_	_	20	P	_	_
		
1	In	_	IN	_	_	11	VMOD	_	_
2	contrast	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	11	P	_	_
4	less	_	JJR	_	_	6	DEP	_	_
5	than	_	IN	_	_	6	DEP	_	_
6	5	_	CD	_	_	7	NMOD	_	_
7	%	_	NN	_	_	11	VMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	DNA	_	NN	_	_	8	PMOD	_	_
11	was	_	VBD	_	_	0	ROOT	_	_
12	fragmented	_	JJ	_	_	11	VMOD	_	_
13	in	_	IN	_	_	11	VMOD	_	_
14	cells	_	NNS	_	_	13	PMOD	_	_
15	incubated	_	VBN	_	_	14	APPO	_	_
16	with	_	IN	_	_	15	VMOD	_	_
17	GM-CSF	_	NN	_	_	16	PMOD	_	_
18	plus	_	CC	_	_	17	COORD	_	_
19	FBS	_	NN	_	_	18	CONJ	_	_
20	or	_	CC	_	_	19	COORD	_	_
21	GM-CSF	_	NN	_	_	20	CONJ	_	_
22	alone	_	RB	_	_	19	NMOD	_	_
23	.	_	.	_	_	11	P	_	_
		
1	Delayed	_	VBN	_	_	2	NMOD	_	_
2	addition	_	NN	_	_	10	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	GM-CSF	_	NN	_	_	3	PMOD	_	_
5	,	_	,	_	_	4	P	_	_
6	but	_	CC	_	_	4	COORD	_	_
7	not	_	RB	_	_	6	COORD	_	_
8	FBS	_	NN	_	_	6	CONJ	_	_
9	,	_	,	_	_	4	P	_	_
10	permitted	_	VBD	_	_	0	ROOT	_	_
11	partial	_	JJ	_	_	12	NMOD	_	_
12	rescue	_	NN	_	_	10	VMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	cells	_	NNS	_	_	13	PMOD	_	_
16	,	_	,	_	_	10	P	_	_
17	inhibiting	_	VBG	_	_	10	VMOD	_	_
18	increasing	_	VBG	_	_	19	NMOD	_	_
19	rates	_	NNS	_	_	17	VMOD	_	_
20	of	_	IN	_	_	19	NMOD	_	_
21	accumulation	_	NN	_	_	20	PMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	fragmented	_	JJ	_	_	24	NMOD	_	_
24	DNA	_	NN	_	_	22	PMOD	_	_
25	.	_	.	_	_	10	P	_	_
		
1	When	_	WRB	_	_	17	VMOD	_	_
2	the	_	DT	_	_	6	NMOD	_	_
3	macro-molecular	_	JJ	_	_	6	NMOD	_	_
4	synthesis	_	NN	_	_	6	NMOD	_	_
5	inhibitor	_	NN	_	_	6	NMOD	_	_
6	cycloheximide	_	NN	_	_	17	VMOD	_	_
7	(	_	(	_	_	8	P	_	_
8	CHX	_	NN	_	_	6	PRN	_	_
9	)	_	)	_	_	8	P	_	_
10	or	_	CC	_	_	6	COORD	_	_
11	actinomycin	_	NN	_	_	12	NMOD	_	_
12	D	_	NN	_	_	10	CONJ	_	_
13	(	_	(	_	_	15	P	_	_
14	Act	_	VB	_	_	15	NMOD	_	_
15	D	_	NN	_	_	12	PRN	_	_
16	)	_	)	_	_	15	P	_	_
17	was	_	VBD	_	_	31	VMOD	_	_
18	present	_	JJ	_	_	17	VMOD	_	_
19	for	_	IN	_	_	17	VMOD	_	_
20	26	_	CD	_	_	21	NMOD	_	_
21	hours	_	NNS	_	_	19	PMOD	_	_
22	in	_	IN	_	_	17	VMOD	_	_
23	the	_	DT	_	_	24	NMOD	_	_
24	absence	_	NN	_	_	22	PMOD	_	_
25	of	_	IN	_	_	24	NMOD	_	_
26	GM-CSF	_	NN	_	_	25	PMOD	_	_
27	and	_	CC	_	_	26	COORD	_	_
28	FBS	_	NN	_	_	27	CONJ	_	_
29	,	_	,	_	_	31	P	_	_
30	apoptosis	_	NN	_	_	31	VMOD	_	_
31	was	_	VBD	_	_	0	ROOT	_	_
32	inhibited	_	VBN	_	_	31	VC	_	_
33	.	_	.	_	_	31	P	_	_
		
1	In	_	IN	_	_	13	VMOD	_	_
2	contrast	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	13	P	_	_
4	in	_	IN	_	_	13	VMOD	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	presence	_	NN	_	_	4	PMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	GM-CSF	_	NN	_	_	7	PMOD	_	_
9	or	_	CC	_	_	8	COORD	_	_
10	FBS	_	NN	_	_	9	CONJ	_	_
11	,	_	,	_	_	13	P	_	_
12	apoptosis	_	NN	_	_	13	VMOD	_	_
13	was	_	VBD	_	_	0	ROOT	_	_
14	enhanced	_	VBN	_	_	13	VC	_	_
15	upon	_	IN	_	_	14	VMOD	_	_
16	addition	_	NN	_	_	15	PMOD	_	_
17	of	_	IN	_	_	16	NMOD	_	_
18	CHX	_	NN	_	_	17	PMOD	_	_
19	or	_	CC	_	_	18	COORD	_	_
20	Act	_	VB	_	_	21	NMOD	_	_
21	D	_	NN	_	_	19	CONJ	_	_
22	.	_	.	_	_	13	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	latter	_	JJ	_	_	3	NMOD	_	_
3	effect	_	NN	_	_	4	VMOD	_	_
4	persisted	_	VBD	_	_	0	ROOT	_	_
5	even	_	RB	_	_	4	VMOD	_	_
6	with	_	IN	_	_	4	VMOD	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	late	_	JJ	_	_	9	NMOD	_	_
9	addition	_	NN	_	_	6	PMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	CHX	_	NN	_	_	10	PMOD	_	_
12	.	_	.	_	_	4	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	findings	_	NNS	_	_	3	VMOD	_	_
3	indicate	_	VBP	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	disparate	_	JJ	_	_	6	NMOD	_	_
6	mechanisms	_	NNS	_	_	12	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	enhancing	_	VBG	_	_	7	PMOD	_	_
9	or	_	CC	_	_	8	COORD	_	_
10	inhibiting	_	VBG	_	_	9	CONJ	_	_
11	apoptosis	_	NN	_	_	10	VMOD	_	_
12	exist	_	VBP	_	_	4	SUB	_	_
13	in	_	IN	_	_	12	VMOD	_	_
14	myeloid	_	JJ	_	_	16	NMOD	_	_
15	leukemic	_	JJ	_	_	16	NMOD	_	_
16	cells	_	NNS	_	_	13	PMOD	_	_
17	related	_	JJ	_	_	16	APPO	_	_
18	to	_	TO	_	_	17	AMOD	_	_
19	environmental	_	JJ	_	_	20	NMOD	_	_
20	conditions	_	NNS	_	_	18	PMOD	_	_
21	,	_	,	_	_	20	P	_	_
22	including	_	VBG	_	_	20	NMOD	_	_
23	HGF-regulated	_	JJ	_	_	25	NMOD	_	_
24	cellular	_	JJ	_	_	25	NMOD	_	_
25	synthesis	_	NN	_	_	22	PMOD	_	_
26	of	_	IN	_	_	25	NMOD	_	_
27	distinct	_	JJ	_	_	28	NMOD	_	_
28	proteins	_	NNS	_	_	26	PMOD	_	_
29	and	_	CC	_	_	28	COORD	_	_
30	mRNA	_	NN	_	_	29	CONJ	_	_
31	.	_	.	_	_	3	P	_	_
		
